SWHR Policy Resources

Endometriosis Advocacy Toolkit

SWHR Policy Agenda: Improving Women’s Heart Health Outcomes Across the Lifespan

Heart disease is the leading cause of death for both women and men in the United States, resulting in one...

Federal Agencies’ Work in Autoimmune Diseases and Conditions

This policy brief demonstrates how federal agencies are contributing to improved health and health care for women across the lifespan...

The Need for Diversity in Autoimmune Disease Research Trials

This policy brief reviews how the exclusion of any population from autoimmune clinical trials limits our understanding of these diseases...

Prioritizing Federal Research on Autoimmune and Immune-Mediated Diseases and Conditions

This policy brief discusses the state of autoimmune disease research funding and highlight how robust and sustained for this research...

Issues Affecting Health Care Coverage and Access for Women with Autoimmune Diseases and Conditions

This policy brief highlights how certain coverage policies, such as prior authorization and step therapy, can affect women and their...

Improving Outcomes for Women with Autoimmune Diseases and Conditions: A Call to Action

The Autoimmune Diseases Policy Agenda is intended to serve as a roadmap outlining key areas of policy need to improve...

SWHR Policy Agenda: Breaking Down the Burden of Alzheimer’s Disease for Women

The Alzheimer's Disease Policy Agenda acts as a roadmap of policy needs to improve Alzheimer's and related dementias outcomes for...

Promoting Bone Health Through Policy: A Call to Action

The Bone Health Policy Agenda intends to serve as a roadmap outlining key areas of policy needed to improve the...

Utilization Management Policies and Autoimmune Diseases: A Women’s Health Issue

This fact sheet provides an overview of autoimmune and immune-mediated diseases are and the related utilization management (UM) policies.

Fibroid Awareness Month Toolkit

July is Fibroid Awareness Month, a time to raise awareness for uterine fibroids and the policy changes needed to improve...

Position Statement: Women and COVID-19

Policies that address COVID-19 prevention, treatment, and pandemic relief must consider sex as a biological variable as well as the...

Position Statement: Advancement of Women in the Biomedical Workforce

SWHR supports efforts that improve the representation of women and other historically underrepresented groups within all levels of the biomedical...

Position Statement: Improving Women’s Health Equity

Sex and gender, race and ethnicity, identity, faith, disability status, pregnancy, socioeconomic status, incarceration, and immigration status should not impede...

Position Statement: Investment in Women’s Health Research

The federal government must support research that addresses the unique health needs of women across the lifespan. SWHR recommends continued...

Position Statement: Inclusion of Sex as a Biological Variable in Research

Research must take into account sex as a biological variable (SABV) in order to better understand its impact on health...

Position Statement: Inclusion of Pregnant and Lactating Populations in Research

In line with our mission to ensure women’s participation in biomedical research, SWHR strongly supports appropriate inclusion of pregnant and...

SWHR’s 2022 Health Care Value Assessment Principles

These 2022 Principles reflect on the current health care value assessment landscape and identify additional opportunities to promote patient-centered value,...

SWHR Principles Addressing Disparities in Drug Development

SWHR developed principles designed to address issues of sex and gender disparities in drug development within the FDA's PFDD program.